Dr. Patrick Soon-Shiong

ImmunityBio responds to FDA warning letter with new protocols

ImmunityBio's new protocols aim to ensure that promotional communications are “accurate, balanced and compliant with FDA regulations," the company said.

Kevin Dunleavy Apr 6, 2026 3:10pm